Company
United StatesHaydar A. Frangoul, MD Program Director, Nashville, TN – FDA Inspections
Inspection records and compliance data for Haydar A. Frangoul, MD Program Director in Nashville, Tennessee. 3 FDA inspections on record, last inspected June 05, 2026.
Company Profile
This profile covers Haydar A. Frangoul, MD Program Director based in Nashville, Tennessee, United States.
FDA Inspection History
- FDA inspections
- 3
- OAI
- 0
- VAI
- 0
- NAI
- 2
- Unclassified
- 1
- Form 483s
- 0
- Warning letters
- 0
First inspected January 9, 2013. Last inspected June 5, 2026.
FDA inspections (3)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| June 5, 2026 | Not classified | Biologics | 1321496 |
| September 15, 2023 | NAI | Biologics · Bioresearch Monitoring | 1219041 |
| January 9, 2013 | NAI | Human Drugs · Bioresearch Monitoring | 815013 |
FDA documents
No Form 483s, Warning Letters or EIRs on record.
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
Haydar A. Frangoul, MD Program Director
FEI Number
3009968483
Address
Sarah Cannon Pediatric Hematology/Oncology & Cellular Therapy @Tristar Centennial, 330 23rd Ave North, Suite 450, Nashville, Tennessee 37232, United States
Country
United States
ID: 9d510fbd-0be6-4a20-837b-7f6e0c784cde